AKBA logo

Akebia Therapeutics (AKBA) Company Overview

Profile

Full Name:

Akebia Therapeutics, Inc.

Sector:

Healthcare

Country:

United States

IPO:

March 20, 2014

Indexes:

Not included

Description:

Akebia Therapeutics (AKBA) is a biopharmaceutical company focused on developing and commercializing innovative therapies for kidney diseases. Their main goal is to improve the lives of patients with chronic kidney disease by providing effective treatments that enhance kidney function and overall health.

Events Calendar

Earnings

Next earnings date:

Mar 13, 2025

Recent quarterly earnings:

Nov 7, 2024

Recent annual earnings:

Mar 14, 2024
Dividend

Next ex-dividend date:

N/A

Recent ex-dividend date:

N/A
Splits

Next split:

N/A

Recent split:

N/A

Analyst ratings

Recent major analysts updates

Jan 23, 25 HC Wainwright & Co.
Buy
Jan 14, 25 HC Wainwright & Co.
Buy
Oct 23, 24 HC Wainwright & Co.
Buy
Oct 10, 24 HC Wainwright & Co.
Buy
Oct 8, 24 HC Wainwright & Co.
Buy
Sep 6, 24 HC Wainwright & Co.
Buy
Aug 12, 24 HC Wainwright & Co.
Buy
Mar 28, 24 HC Wainwright & Co.
Buy
Mar 15, 24 HC Wainwright & Co.
Buy
Nov 17, 23 HC Wainwright & Co.
Buy

Market Data

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Price

Market cap

Technical

Dividend

Profitability

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Profit

EPS

ROA & ROE

EBIT & EBITDA

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PB Ratio

PS Ratio

Enterprise value

EV/EBITDA

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Leverage

Risk & Stability

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Equity

Liabilities

Debt

Expenses

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cash Flow

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Free CashFlow

CAPEX

Institutional Ownership

FAQ

  • What is the ticker symbol for Akebia Therapeutics?
  • Does Akebia Therapeutics pay dividends?
  • What sector is Akebia Therapeutics in?
  • What industry is Akebia Therapeutics in?
  • What country is Akebia Therapeutics based in?
  • When did Akebia Therapeutics go public?
  • Is Akebia Therapeutics in the S&P 500?
  • Is Akebia Therapeutics in the NASDAQ 100?
  • Is Akebia Therapeutics in the Dow Jones?
  • When was Akebia Therapeutics's last earnings report?
  • When does Akebia Therapeutics report earnings?
  • Should I buy Akebia Therapeutics stock now?

What is the ticker symbol for Akebia Therapeutics?

The ticker symbol for Akebia Therapeutics is NASDAQ:AKBA

Does Akebia Therapeutics pay dividends?

No, Akebia Therapeutics does not pay dividends

What sector is Akebia Therapeutics in?

Akebia Therapeutics is in the Healthcare sector

What industry is Akebia Therapeutics in?

Akebia Therapeutics is in the Drug Manufacturers - Specialty & Generic industry

What country is Akebia Therapeutics based in?

Akebia Therapeutics is headquartered in United States

When did Akebia Therapeutics go public?

Akebia Therapeutics's initial public offering (IPO) was on March 20, 2014

Is Akebia Therapeutics in the S&P 500?

No, Akebia Therapeutics is not included in the S&P 500 index

Is Akebia Therapeutics in the NASDAQ 100?

No, Akebia Therapeutics is not included in the NASDAQ 100 index

Is Akebia Therapeutics in the Dow Jones?

No, Akebia Therapeutics is not included in the Dow Jones index

When was Akebia Therapeutics's last earnings report?

Akebia Therapeutics's most recent earnings report was on Nov 7, 2024

When does Akebia Therapeutics report earnings?

The next expected earnings date for Akebia Therapeutics is Mar 13, 2025

Should I buy Akebia Therapeutics stock now?

As of today, analysts generally recommend a 'Buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions